Biosenic SA (BIOS) NPV

Sell:€0.00Buy:€0.00€0.00 (10.00%)

Prices delayed by at least 15 minutes
Sell:€0.00
Buy:€0.00
Change:€0.00 (10.00%)
Prices delayed by at least 15 minutes
Sell:€0.00
Buy:€0.00
Change:€0.00 (10.00%)
Prices delayed by at least 15 minutes

Company Information

About this company

Biosenic SA formerly known as Bone Therapeutics SA is a Belgium-based company developing cell therapy products. The Company develops cell therapy products for the treatment and regeneration of bone tissue and bone reconstruction applications, osteonecrosis, ununited fractures, and maxillo-facial reconstruction. It is engaged in research, enable adult stem cell isolation, expansion, and osteogenic differentiation. The Company’s therapeutic area focus is bone diseases, with extensions to joint, mainly osteoarthritis and disc degeneration. It also provides cell therapy platform for tissue repair protection with an entirely new arsenal of various anti-inflammatory and anti-autoimmune formulations using the immunomodulatory properties of ATO/OATO (Arsenic trioxide/ Oral arsenic trioxide).

Key people

Francois Rieger
Executive Chairman of the Board, Chief Executive Officer
Veronique Pomi Schneiter
Deputy Chief Executive Officer, Executive Director
Jean-francois Rax
Non-Executive Director
Jeanluc Vandebroek
Non-Executive Director
Claudia D'Augusta
Independent Director
Damian Marron
Independent Director
Gloria Matthews
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    Belgium
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    BE0974280126
  • Market cap
    €1.54m
  • Employees
    11
  • Shares in issue
    383.93m
  • Exchange
    Euronext Brussels
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.